New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- Targeting the Tumor Microenvironment in Cholangiocarcinoma: Implications for The
- 1
- 3 years, 7 months ago
- Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced so
- 1
- 3 years, 7 months ago
- Peroral cholangioscopy-guided forceps biopsy versus fluoroscopy-guided forceps b
- 1
- 3 years, 7 months ago
- The impact of primary sclerosing cholangitis or inflammatory bowel disease on ch
- 1
- 3 years, 7 months ago
- An immunostaining panel of C-reactive protein, N-cadherin, and S100P is useful f
- 1
- 3 years, 7 months ago
- Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarc
- 1
- 3 years, 7 months ago
- Efficacy and safety of EUS biliary drainage in malignant distal and hilar biliar
- 1
- 3 years, 7 months ago
- Peroral cholangioscopy-guided forceps biopsy versus fluoroscopy-guided forceps b
- 1
- 3 years, 7 months ago
- The impact of primary sclerosing cholangitis or inflammatory bowel disease on ch
- 1
- 3 years, 7 months ago
- Multifocal pancreatobiliary malignancies: A diagnostic and therapeutic challenge
- 1
- 3 years, 7 months ago
- Prognostic value of the controlling nutritional status (CONUT) score in intrahep
- 1
- 3 years, 7 months ago
- Our emerging understanding of the roles of long non-coding RNAs in normal liver
- 1
- 3 years, 7 months ago
- ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable
- 1
- 3 years, 7 months ago
- The forum ‘New Developments’ is closed to new topics and replies.